Serum immunoglobulins and lymphocyte subsets in chronic lymphocytic leukemia
- PMID: 2948384
- DOI: 10.1093/ajcp/87.1.60
Serum immunoglobulins and lymphocyte subsets in chronic lymphocytic leukemia
Abstract
The concentrations of serum immunoglobulins were correlated to the stage of disease and the proportions of peripheral blood lymphocyte subsets in 25 untreated patients with B-cell chronic lymphocytic leukemia (CLL). Diminished levels of at least one serum immunoglobulin were present in 77% of all patients with CLL and 73% of patients with Stage 0 disease. The mean concentration of IgG, IgM, and IgA decreased with advancing stage of CLL. The percentages of total T, T-helper (TH), and T-suppressor (TS) cells in the peripheral blood were less in patients with CLL than in healthy persons, but the absolute concentrations of total T, TH, and TS cells were greater in patients with CLL than controls (P less than 0.02). The absolute number of B-cells (P less than 0.01) and null cells (P less than 0.001) was also increased in patients with CLL, particularly those patients in advanced stages of CLL. These findings suggest that the hypogammaglobulinemia associated with CLL first occurs during the earliest stage of disease and may be related to the alterations in the proportion of peripheral blood lymphocytes.
Similar articles
-
Immunoglobulin secretory function of B cells from untreated patients with chronic lymphocytic leukemia and hypogammaglobulinemia: role of T cells.Blood. 1983 Oct;62(4):767-74. Blood. 1983. PMID: 6224523
-
Expression of NK-lineage markers on peripheral blood lymphocytes with T-helper (Leu3+/T4+) phenotype in B cell chronic lymphocytic leukemia.Blood. 1985 Jan;65(1):149-55. Blood. 1985. PMID: 3155487
-
Imbalance of T-cell subpopulations does not result in defective helper function in chronic lymphocytic leukemia.Cancer. 1981 Oct 15;48(8):1754-60. doi: 10.1002/1097-0142(19811015)48:8<1754::aid-cncr2820480811>3.0.co;2-7. Cancer. 1981. PMID: 6456808
-
A review of the prognostic role of cytogenetic, phenotypic, morphologic, and immune function characteristics in chronic lymphocytic leukemia.Blood Cells. 1987;12(2):327-38. Blood Cells. 1987. PMID: 3304471 Review.
-
The human T-cell leukemias: clinical, cytomorphologic, immunophenotypic, and genotypic characteristics.Hum Pathol. 1986 Jan;17(1):14-33. doi: 10.1016/s0046-8177(86)80151-4. Hum Pathol. 1986. PMID: 3002948 Review.
Cited by
-
Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes.Cancer. 2015 Sep 1;121(17):2883-91. doi: 10.1002/cncr.29438. Epub 2015 Apr 30. Cancer. 2015. PMID: 25931291 Free PMC article.
-
Secondary Immunodeficiency Frequency in Patients with Chronic Lymphocytic Leukemia: The Relationship with Stage and Treatment.Int J Hematol Oncol Stem Cell Res. 2022 Jan 1;16(1):14-21. doi: 10.18502/ijhoscr.v16i1.8437. Int J Hematol Oncol Stem Cell Res. 2022. PMID: 35975119 Free PMC article.
-
Biclonal Gammopathy in Chronic Lymphocytic Leukemia: Case Report and Review of the Literature.Oman Med J. 2015 May;30(3):216-8. doi: 10.5001/omj.2015.45. Oman Med J. 2015. PMID: 26171130 Free PMC article.
-
Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway.Blood. 2010 Apr 1;115(13):2619-29. doi: 10.1182/blood-2009-09-242438. Epub 2009 Nov 24. Blood. 2010. PMID: 19965642 Free PMC article. Clinical Trial.
-
Evaluation of Periodontal Parameters in Patients with Early Stage Chronic Lymphocytic Leukemia.Acta Stomatol Croat. 2016 Mar;50(1):23-33. doi: 10.15644/asc50/1/4. Acta Stomatol Croat. 2016. PMID: 27688423 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous